Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP608494.RAA-gfDLT7bgUd9WickF0mvBaYEZWLEedOGRzuuntkroM130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP608494.RAA-gfDLT7bgUd9WickF0mvBaYEZWLEedOGRzuuntkroM130_assertion type Assertion NP608494.RAA-gfDLT7bgUd9WickF0mvBaYEZWLEedOGRzuuntkroM130_head.
- NP608494.RAA-gfDLT7bgUd9WickF0mvBaYEZWLEedOGRzuuntkroM130_assertion description "[Measures of expression of the M2 cell markers CD14, CD68, CD163, and CD204, which are elevated in high-grade gliomas, and the neutrophil/myeloid-derived suppressor cell (MDSC) subset marker CD15, which is reduced, provide the best index of glioma grade.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP608494.RAA-gfDLT7bgUd9WickF0mvBaYEZWLEedOGRzuuntkroM130_provenance.
- NP608494.RAA-gfDLT7bgUd9WickF0mvBaYEZWLEedOGRzuuntkroM130_assertion evidence source_evidence_literature NP608494.RAA-gfDLT7bgUd9WickF0mvBaYEZWLEedOGRzuuntkroM130_provenance.
- NP608494.RAA-gfDLT7bgUd9WickF0mvBaYEZWLEedOGRzuuntkroM130_assertion SIO_000772 23741072 NP608494.RAA-gfDLT7bgUd9WickF0mvBaYEZWLEedOGRzuuntkroM130_provenance.
- NP608494.RAA-gfDLT7bgUd9WickF0mvBaYEZWLEedOGRzuuntkroM130_assertion wasDerivedFrom befree-20140225 NP608494.RAA-gfDLT7bgUd9WickF0mvBaYEZWLEedOGRzuuntkroM130_provenance.
- NP608494.RAA-gfDLT7bgUd9WickF0mvBaYEZWLEedOGRzuuntkroM130_assertion wasGeneratedBy ECO_0000203 NP608494.RAA-gfDLT7bgUd9WickF0mvBaYEZWLEedOGRzuuntkroM130_provenance.